These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 31181069)
1. Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study. Petrykey K; Lippé S; Robaey P; Sultan S; Laniel J; Drouin S; Bertout L; Beaulieu P; St-Onge P; Boulet-Craig A; Rezgui A; Yasui Y; Sapkota Y; Krull KR; Hudson MM; Laverdière C; Sinnett D; Krajinovic M PLoS One; 2019; 14(6):e0217314. PubMed ID: 31181069 [TBL] [Abstract][Full Text] [Related]
2. Genetic Factors and Long-term Treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood Leukemia Survivors: An Exome-Wide Association Study. Petrykey K; Lippé S; Sultan S; Robaey P; Drouin S; Affret-Bertout L; Beaulieu P; St-Onge P; Baedke JL; Yasui Y; Hudson MM; Laverdière C; Sinnett D; Krajinovic M Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):234-243. PubMed ID: 38051303 [TBL] [Abstract][Full Text] [Related]
3. Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia. Radtke S; Zolk O; Renner B; Paulides M; Zimmermann M; Möricke A; Stanulla M; Schrappe M; Langer T Blood; 2013 Jun; 121(26):5145-53. PubMed ID: 23652803 [TBL] [Abstract][Full Text] [Related]
17. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Langer T; Martus P; Ottensmeier H; Hertzberg H; Beck JD; Meier W Med Pediatr Oncol; 2002 May; 38(5):320-8. PubMed ID: 11979456 [TBL] [Abstract][Full Text] [Related]
18. Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia. Kähkönen M; Metsähonkala L; Minn H; Utriainen T; Korhonen T; Norvasuo-Heilä MK; Harila-Saari A; Aärimaa T; Suhonen-Polvi H; Ruotsalainen U; Solin O; Salmi TT Cancer; 2000 Feb; 88(3):693-700. PubMed ID: 10649265 [TBL] [Abstract][Full Text] [Related]
19. Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors. England J; Drouin S; Beaulieu P; St-Onge P; Krajinovic M; Laverdière C; Levy E; Marcil V; Sinnett D BMC Cancer; 2017 Nov; 17(1):751. PubMed ID: 29126409 [TBL] [Abstract][Full Text] [Related]
20. The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors. Marcoux S; Drouin S; Laverdière C; Alos N; Andelfinger GU; Bertout L; Curnier D; Friedrich MG; Kritikou EA; Lefebvre G; Levy E; Lippé S; Marcil V; Raboisson MJ; Rauch F; Robaey P; Samoilenko M; Séguin C; Sultan S; Krajinovic M; Sinnett D Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27917589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]